Prev:MiR-34b-5p Mediates the Proliferation and Differentiation of Myoblasts by Targeting IGFBP2(ABL1030-5.77)
Next:Tumoral microvesicle–activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma(ABL1020-5.595)